grant

Molecular characteristation of the adiponectin receptors, AdipoR1 and AdipoR2: Identifying strategies to enhance adiponectin sensitivity and reduce cardiometabolic disease. [ 2014 - 2019 ]

Also known as: Defining how novel hormone receptors work to identify new treatments for heart disease.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1074074]

Brief description Obesity and Type 2 diabetes (T2D) increase risk of cardiovascular disease (CVD), a leading cause of death in Australia. New drugs are required to reduce the health risks and financial burden of these diseases. Targeting hormone receptors to reduce fat storage in liver and skeletal muscle in obesity may improve insulin sensitivity and reduce blood sugar levels and therefore reduce CVD risk. This research will study how these receptors function in order to develop new drugs to reduce CVD risk.

Funding Amount $AUD 334,634.55

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857